These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11920608)

  • 1. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.
    Violette S; Poulain L; Dussaulx E; Pepin D; Faussat AM; Chambaz J; Lacorte JM; Staedel C; Lesuffleur T
    Int J Cancer; 2002 Apr; 98(4):498-504. PubMed ID: 11920608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins.
    Nita ME; Nagawa H; Tominaga O; Tsuno N; Fujii S; Sasaki S; Fu CG; Takenoue T; Tsuruo T; Muto T
    Br J Cancer; 1998 Oct; 78(8):986-92. PubMed ID: 9792140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to apoptosis is increased during metastatic dissemination of colon cancer.
    Oliver L; Cordel S; Barbieux I; LeCabellec MT; Meflah K; Grégoire M; Vallette FM
    Clin Exp Metastasis; 2002; 19(2):175-80. PubMed ID: 11964082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed.
    Peters GJ; van Triest B; Backus HH; Kuiper CM; van der Wilt CL; Pinedo HM
    Eur J Cancer; 2000 May; 36(7):916-24. PubMed ID: 10785598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy.
    Sui X; Kong N; Wang X; Fang Y; Hu X; Xu Y; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan H; Han W
    Sci Rep; 2014 Apr; 4():4694. PubMed ID: 24733045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53.
    Pagliara V; Saide A; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Russo G; Russo A
    Oncotarget; 2016 Aug; 7(31):50333-50348. PubMed ID: 27385096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53.
    Borralho PM; Moreira da Silva IB; Aranha MM; Albuquerque C; Nobre Leitão C; Steer CJ; Rodrigues CM
    Biochim Biophys Acta; 2007 Jan; 1772(1):40-7. PubMed ID: 17056233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
    Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
    Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX.
    Nehls O; Okech T; Hsieh CJ; Enzinger T; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Hass HG; Arkenau HT; Hartmann JT; Porschen R; Gregor M; Klump B
    Br J Cancer; 2007 May; 96(9):1409-18. PubMed ID: 17426704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of BAX in the apoptotic response to anticancer agents.
    Zhang L; Yu J; Park BH; Kinzler KW; Vogelstein B
    Science; 2000 Nov; 290(5493):989-92. PubMed ID: 11062132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of wild-type p53 stimulates an increase in both Bax and Bcl-xL protein content in HT29 cells.
    Merchant AK; Loney TL; Maybaum J
    Oncogene; 1996 Dec; 13(12):2631-7. PubMed ID: 9000137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.
    Christodoulopoulos G; Fotouhi N; Krajewski S; Reed JC; Alaoui-Jamali M; Panasci L
    Cancer Lett; 1997 Dec; 121(1):59-67. PubMed ID: 9459175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin.
    Lim DY; Park JH
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells.
    Watson JL; Hill R; Yaffe PB; Greenshields A; Walsh M; Lee PW; Giacomantonio CA; Hoskin DW
    Cancer Lett; 2010 Nov; 297(1):1-8. PubMed ID: 20472336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of bax in human glioma cell lines.
    Vogelbaum MA; Tong JX; Perugu R; Gutmann DH; Rich KM
    J Neurosurg; 1999 Sep; 91(3):483-9. PubMed ID: 10470825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The β6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer.
    Liu S; Wang J; Niu W; Liu E; Wang J; Peng C; Lin P; Wang B; Khan AQ; Gao H; Liang B; Shahbaz M; Niu J
    Cancer Lett; 2013 Jan; 328(2):325-34. PubMed ID: 23073477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells.
    Butt AJ; Firth SM; King MA; Baxter RC
    J Biol Chem; 2000 Dec; 275(50):39174-81. PubMed ID: 10998426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.